These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12544663)

  • 1. Kinetic studies of lipoprotein metabolism in the metabolic syndrome including effects of nutritional interventions.
    Barrett PH; Watts GF
    Curr Opin Lipidol; 2003 Feb; 14(1):61-8. PubMed ID: 12544663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish oils, phytosterols and weight loss in the regulation of lipoprotein transport in the metabolic syndrome: lessons from stable isotope tracer studies.
    Watts GF; Chan DC; Ooi EM; Nestel PJ; Beilin LJ; Barrett PH
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):877-82. PubMed ID: 16922825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent studies of lipoprotein kinetics in the metabolic syndrome and related disorders.
    Chan DC; Barrett PH; Watts GF
    Curr Opin Lipidol; 2006 Feb; 17(1):28-36. PubMed ID: 16407713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studies.
    Chan DC; Barrett PH; Watts GF
    Clin Sci (Lond); 2004 Sep; 107(3):221-32. PubMed ID: 15225121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein transport in the metabolic syndrome: pathophysiological and interventional studies employing stable isotopy and modelling methods.
    Chan DC; Barrett PH; Watts GF
    Clin Sci (Lond); 2004 Sep; 107(3):233-49. PubMed ID: 15225143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the investigation of lipoprotein metabolism using tracer methodology.
    Chan DC; Watts GF
    Clin Lab; 2006; 52(7-8):353-61. PubMed ID: 16955633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant sterol-enriched margarine lowers plasma LDL in hyperlipidemic subjects with low cholesterol intake: effect of fibrate treatment.
    Nigon F; Serfaty-Lacrosnière C; Beucler I; Chauvois D; Neveu C; Giral P; Chapman MJ; Bruckert E
    Clin Chem Lab Med; 2001 Jul; 39(7):634-40. PubMed ID: 11522112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat.
    Morgado N; Rigotti A; Valenzuela A
    Ann Nutr Metab; 2005; 49(6):397-406. PubMed ID: 16227687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome, Dyslipidemia and Regulation of Lipoprotein Metabolism.
    Iqbal J; Al Qarni A; Hawwari A; Alghanem AF; Ahmed G
    Curr Diabetes Rev; 2018; 14(5):427-433. PubMed ID: 28677496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary modification and fish oil supplementation on dyslipoproteinemia in pediatric systemic lupus erythematosus.
    Ilowite NT; Copperman N; Leicht T; Kwong T; Jacobson MS
    J Rheumatol; 1995 Jul; 22(7):1347-51. PubMed ID: 7562770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects.
    Meyer BJ; Hammervold T; Rustan AC; Howe PR
    Lipids; 2007 Mar; 42(2):109-15. PubMed ID: 17393216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein metabolism and renal failure.
    Attman PO; Samuelsson O; Alaupovic P
    Am J Kidney Dis; 1993 Jun; 21(6):573-92. PubMed ID: 8503411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
    Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
    Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome.
    Arca M
    Atheroscler Suppl; 2015 Feb; 17():12-6. PubMed ID: 25659871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease.
    Quaschning T; Krane V; Metzger T; Wanner C
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S14-9. PubMed ID: 11576915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrates, dyslipoproteinaemia and cardiovascular disease.
    Watts GF; Dimmitt SB
    Curr Opin Lipidol; 1999 Dec; 10(6):561-74. PubMed ID: 10680050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary fatty acids, dietary patterns, and lipoprotein metabolism.
    Lamarche B; Couture P
    Curr Opin Lipidol; 2015 Feb; 26(1):42-7. PubMed ID: 25551801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.
    Shepherd J; Betteridge J; Van Gaal L;
    Curr Med Res Opin; 2005 May; 21(5):665-82. PubMed ID: 15969866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simplified approach to lipoprotein kinetics and factors affecting serum cholesterol and triglyceride concentrations.
    Hopkins PN; Williams RR
    Am J Clin Nutr; 1981 Nov; 34(11):2560-90. PubMed ID: 7030050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.